SHILPAMED943.00

Shilpa Medicare Ltd.

· Pharma & Health
₹ CrorePeersNATCOPHARMSPARCSTARRUBICONSUPRIYATHYROCAREVIYASHPARKHOSPSMcap ₹18,445 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Inventory Days (DIO)296.71362.56284.24284.24
Receivable Days (DSO)124.26125.08123.06123.06
Payable Days (DPO)150.3899.39110.41103.90
Cash Conversion Cycle (days)270.59388.25296.89303.40
Working Capital Turnover6.284.135.886.43
Asset Turnover0.370.390.420.42
Cash Conversion (CFO/Net Income)4.251.691.411.41
CFO/EBITDA0.550.420.790.79
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.